Yüklüyor......
Advances in the Treatment of Pancreatic Neuroendocrine Tumors (pNETs)
Recent clinical trials have led to significant advancements in treatment options for metastatic neuroendocrine tumors of the pancreas. Sunitinib and everolimus have been approved by the Food and Drug Administration for treatment of progressive pancreatic NETs based on phase III trial data demonstrat...
Kaydedildi:
| Yazar: | |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
International Society of Gastrointestinal Oncology
2013
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3849907/ https://ncbi.nlm.nih.gov/pubmed/24312683 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|